Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects
Clinical trial NCT04480957 · COMPLETED
Trial details
- NCT number
- NCT04480957
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2021-01-29
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.